Showing results (11-20 of 40) with videos related to
Sort By:
Pageof 4
Annals of Surgical Oncology|January 3, 2024
Initial Report: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic CancerAustin M Eckhoff, Elishama Kanu, Ashley Fletcher, et al.Scientific Reports|November 23, 2017
miR-500a-5p regulates oxidative stress response genes in breast cancer and predicts cancer survivalDavide Degli Esposti, Vasily N Aushev, Eunjee Lee, et al.Journal for Immunotherapy of Cancer|February 1, 2022
Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancerPashtoon Murtaza Kasi, Griffin Budde, Michael Krainock, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2025
Tumor-informed ctDNA assay to predict outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with PD-1 inhibitorNatasha Honoré, George Laliotis, Vasily N Aushev, et al.Nature Cell Biology|September 24, 2013
The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune responseMichal Simicek, Sam Lievens, Mathias Laga, et al.EMBO Molecular Medicine|February 17, 2016
OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitinationMaria Francesca Baietti, Michal Simicek, Layka Abbasi Asbagh, et al.The Oncologist|December 23, 2022
Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell CarcinomaGeorges Azzi, Mehrad Tavallai, Vasily N Aushev, et al.JCO Precision Oncology|December 6, 2024
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete ResponseEric Michael Lander, Vasily N Aushev, Brandon M Huffman, et al.Scientific Reports|April 29, 2020
Gene expression profiles for low-dose exposure to diethyl phthalate in rodents and humans: a translational study with implications for breast carcinogenesisKalpana Gopalakrishnan, Vasily N Aushev, Fabiana Manservisi, et al.Nature Cancer|October 17, 2022
A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genesJoshua J Gruber, Anosheh Afghahi, Kirsten Timms, et al.Pageof 4